We were honoured to welcome Lord Vallance of Balham KCB, Minister for Science, Research and Innovation, to our headquarters at the Babraham Research Campus in Cambridge yesterday. We gave the Minister a tour of our labs and showed him our pioneering work in the field of engineering biology, where we're pushing the boundaries of what is possible in cell programming, by industrialising the manufacture of human cells and making them more accessible. Together, we discussed the future of biotech innovation in the UK, the importance of supporting cutting-edge research, and how government and industry can work together to accelerate progress in science and health. #Innovation #Biotech #ResearchAndDevelopment #ScienceSuperpower #SyntheticBiology #UKScience #bitbio #Cambridge #Health
bit.bio
Biotechnology Research
Cambridge, Cambridgeshire 19,104 followers
The Cell Coding Company
About us
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks
- Website
-
https://bit.bio
External link for bit.bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Privately Held
- Founded
- 2016
- Specialties
- biotechnology, cell type, life science, pharmaceutical drug discovery, High throughput screening, and cell therapy
Locations
-
Primary
The Dorothy Hodgkin Building
Babraham Research Campus
Cambridge, Cambridgeshire CB22 3FH, GB
Employees at bit.bio
Updates
-
📢 NEW DATA from bit.bio's human iPSC-derived ioGlutamatergic Neurons and ioMicroglia highlights how Sartorius successfully maintained healthy neuronal and microglial co-cultures over 50 days. Using continuous live-cell monitoring, the study demonstrated stable network activity and synchronised calcium oscillations, demonstrating consistent, reproducible insights over extended experimental timelines. In a Huntington’s disease model (ioGlutamatergic Neurons HTT 50CAG), disruptions in synaptic signalling shed light on altered cellular communication—offering potential insights into the progression of neurodegenerative diseases. Curious to learn more? https://hubs.ly/Q02SYC9n0 #Neuroscience #iPSCs #LiveCellAnalysis #NeuronalActivity #Microglia #HuntingtonsDisease #optiox #ioCells #sartorius
-
Consideration of mental health and well-being is important year-round, but today on World Mental Health Day, we particularly want to reflect on steps to support our team. Whether alone or with others, it’s important to carve out moments to recharge: 🧘♀️ A Mindfulness Session – A calming break to center ourselves, reduce stress, and boost productivity. 🌿👟 A Wellness Walk – A refreshing walk through nature, taking time to step away from work and clear our minds. 🎨 Creative Wellness Activities – From colouring to creativity sheets, a pause to embrace our artistic sides. Taking care of our mental well-being is a continuous journey. Let’s continue to support one another, today and every day. 💙 #WorldMentalHealthDay #MentalHealthMatters #Mindfulness #WellnessAtWork #bitbio
-
What defines a human dopaminergic neuron? It may seem obvious, but the lack of standardisation in defining, generating and working with human cells poses a major hurdle for neuroscience research. At #SfN2024, scientific experts from Charles River Laboratories, The Michael J. Fox Foundation for Parkinson's Research, and bit.bio emphasised how standardising not only the cells themselves but also the protocols and workflows could improve research outcomes. By minimising variability, we can de-risk research programs and improve reproducibility across labs. So, what steps should be taken to achieve standardisation? Visit us at booth 1545 or share your thoughts in the comments below! #Neuroscience #iPSC #Standardisation #Reproducibility #FutureofScience #ioCells #optiox, Nicole K. Polinski, PhD, Phil Mitchell, Paul Morrill, Farah Patell Socha
-
Today we celebrate #StemCellAwarenessDay and salute all of our peers working to realise the therapeutic potential of stem cell-derived products. Check out our blog to read recent reflections from Professor Roger Pedersen, our Chief Scientific Advisor, and a pioneer in stem cell research, on the evolution of stem cell science and its real-world applications: https://hubs.ly/Q02SLDkS0 #StemCells #RegenerativeMedicine #bitbio #Innovation #RogerPedersen #Medicine
-
We are happy that we are part of the Future Fifty report and in such incredible company, congrats to all. Thank you Tech Nation!
Released Today: The UK's 50 Tech Companies To Watch 👀 🇬🇧 The UK tech industry has a combined market value of more than $1.1 trillion. Much of this value is created by companies who have been through our #FutureFifty programme. 🌟 The Future Fifty counts the UK’s biggest tech success stories – Darktrace, Deliveroo, Monzo Bank, Revolut, Skyscanner and many more – among its all-star alumni, who have collectively raised more than £16.3b. At our inaugural Future Fifty Forum, we announced our latest #FutureFifty cohort to make up this year's 50 companies, spanning the following breakthrough sectors: 👾 AI, AR & Gaming 🧬 BioTech 🌿 ClimateTech 📚 EdTech 💸 FinTech 🏥 HealthTech 👩🏽⚖️ LegalTech ⚛️ Quantum 🧠 SaaS 🪐 SpaceTech 🗺️ TravelTech Read the report to check out insights from the Future Fifty Forum and the 50 companies to watch! 👉 https://lnkd.in/e4tEkpYD Interested in our #FutureFifty programme? Get in touch! 👉 https://lnkd.in/d-Rdp3j Thank you to this year's Future Fifty Programme and Forum Partners HSBC Innovation Banking, Dubai Department of Economy and Tourism, Airwallex, Capsule Insurance, Evelyn Partners, Matchtech, OakNorth, Orrick, Herrington & Sutcliffe LLP and Think & Grow. Carolyn Dawson | Johnny M. | Marco De Novellis | Francesca Arese Lucini Ellie Steel | Puja DeGamia | Rob McManus | Ailsa Taylor Mealings | Steve Brierley | Carolin Krenzer | Simone Maini | Casey Benjamin Swerner
-
Thank you OBN (UK) Ltd, looking forward to the awards ceremony and congratulations to fellow finalists. 🎉
✨ OBN Awards 2024 - Join us to celebrate our finalists on 20 November! ✨ We can't wait to celebrate the amazing innovation and achievement of our finalists at what is set to be another hugely successful OBN Awards evening at the Royal Lancaster in London. Tickets are selling fast for this high-profile life sciences event, with guests keen to show their support, and network with the leading lights of our industry. We have a limited number of table and individual tickets currently available, click the link for more information: https://lnkd.in/e7NCsdgb. Alternatively, please get in touch with us at events@obn.org.uk. Congratulations again to our 2024 OBN Awards finalists! Best Startup Biotech Company, kindly sponsored by Milton Park (Oxfordshire) ⭐ Ambrose Healthcare ⭐ CamGene Therapeutics ⭐ Tessellate BIO Best Emerging Biotech Company, kindly sponsored by Thermo Fisher Scientific ⭐ AviadoBio ⭐ EyeBio ⭐ Ignota Labs Best Established Biotech Company, kindly sponsored by Precision For Medicine ⭐ Adaptimmune ⭐ bit.bio ⭐ Grey Wolf Therapeutics Best Early Stage Medtech Company. kindly sponsored by Penningtons Manches Cooper LLP ⭐ EarSwitch ⭐ Novai ⭐ Radiance Therapeutics Best Established Medtech Company ⭐ Brainomix ⭐ Owlstone Medical ⭐ Perspectum Ltd Most Transformative Healthtech Company of the Year ⭐ Brainomix ⭐ Cyted Health ⭐ Novai Most Impactful CRO of the Year ⭐ Cellomatics Biosciences Ltd ⭐ ImmuONE ⭐ Oxford Biomedica ⭐ PHARMExcel Most Impactful Industry Collaboration of the Year, kindly sponsored by Mills & Reeve ⭐ Pangaea Data ⭐ Poolbeg Pharma plc ⭐ CF AMR Syndicate BioSeed 'One to Watch' Award, kindly sponsored by Partners&. ⭐ Ignota Labs ⭐ MediSieve ⭐ MESOX ⭐ Vitarka Therapeutics Best Industry Support Partner of the Year ⭐ Bulb Interiors, Laboratories & Consulting ⭐ First Create The Media ⭐ Mowbi ⭐ Partners&. The winner of the ‘Special Recognition Award’ and the ‘Emerging Life Sciences Entrepreneur of the Year’ will be announced on the night of the OBN Awards on 20 November. #OBNAwards #LifeSciencesAwards #CelebrateInnovation
-
Hot off the press! We were thrilled to support Tony Oosterveen at the #SfN press conference today on “Pain in the Brain: New Models, Mechanisms and Targets”. Tony was presenting our work on developing ioSensory Neurons and how they can be used as a scalable and physiologically relevant model to develop novel therapeutic targets for pain. Only 50 out of 12,000 abstracts were chosen for press conferences, and we are excited to see our cells getting such recognition. Thank you to the chair Greg Dussor, and congratulations to the other panellists on showcasing their exciting research. See the data yourself: https://lnkd.in/eNbJprvS #bitbio #SfN24 #Neuroscience #DrugDiscovery #ChronicPainResearch #ioCells #optiox
-
It’s day 3 of SfN! Today we have two posters, showcasing how our ioCells neuroscience toolkit can be used for researching excitatory/inhibitory neuron imbalances and to study mitochondrial dysfunction in Huntington's disease. Our experts are looking forward to discussing our data with you! #bitbio #SfN24 #Neuroscience #drugdiscovery
-
Exciting first day at #SfN! We had great engagement around our ioOligodendrocyte-like cell data, with posters presented by our team and Charles River Laboratories, including highly anticipated co-culture results. Missed the posters yesterday? Find our team at booth 1545 - they will be more than happy to walk you through the data. #bitbio #SfN24 #Neuroscience #DrugDiscovery, Tony Oosterveen, Farah Patell Socha, Brittany H.